Bavarian Nordic AS (OCSE:BAVA) Debt-to-Asset : 0.01 (As of Sep. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic AS Debt-to-Asset?

Bavarian Nordic AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr38 Mil. Bavarian Nordic AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr77 Mil. Bavarian Nordic AS's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was kr13,949 Mil. Bavarian Nordic AS's debt to asset for the quarter that ended in Sep. 2024 was 0.01.

Bavarian Nordic AS Debt-to-Asset Historical Data

The historical data trend for Bavarian Nordic AS's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Debt-to-Asset Chart

Bavarian Nordic AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.26

0.05

0.09

0.14

0.01

Bavarian Nordic AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Competitive Comparison of Bavarian Nordic AS's Debt-to-Asset

For the Biotechnology subindustry, Bavarian Nordic AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bavarian Nordic AS's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Debt-to-Asset falls into.

Bavarian Nordic AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bavarian Nordic AS's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(46.546	+	98.756)	/	14353.213
	=	0.01

Bavarian Nordic AS's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(37.652	+	76.649)	/	13948.777
	=	0.01

Bavarian Nordic AS (OCSE:BAVA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Bavarian Nordic AS Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (OCSE:BAVA) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

BVNRY:USA BVNKF:USA BAVAc:UK 0DPB:UK BV3:Germany BAVA:Austria

Address

Philip Heymans Alle 3, Hellerup, DNK, DK-2900

Website

https://www.bavarian-nordic.com

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines